phenytoin has been researched along with Sezary Syndrome in 2 studies
Sezary Syndrome: A form of cutaneous T-cell lymphoma manifested by generalized exfoliative ERYTHRODERMA; PRURITUS; peripheral lymphadenopathy, and abnormal hyperchromatic mononuclear (cerebriform) cells in the skin, LYMPH NODES, and peripheral blood (Sezary cells).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doyle, MF | 1 |
| Anderson, S | 1 |
| Cerrezuela, C | 1 |
| Gabrail, N | 1 |
| D'Incan, M | 1 |
| Souteyrand, P | 1 |
| Bignon, YJ | 1 |
| Fonck, Y | 1 |
| Roger, H | 1 |
2 other studies available for phenytoin and Sezary Syndrome
| Article | Year |
|---|---|
Sézary syndrome associated with phenytoin therapy.
Topics: Aged; Antigens, CD; Flow Cytometry; Humans; Male; Phenytoin; Sezary Syndrome; Time Factors | 1994 |
Hydantoin-induced cutaneous pseudolymphoma with clinical, pathologic, and immunologic aspects of Sézary syndrome.
Topics: Aged; Antigens, CD; Female; Humans; Phenytoin; Sezary Syndrome; Skin Neoplasms | 1992 |